4//SEC Filing
Khan Samina 4
Accession 0001209191-23-001008
CIK 0001358762other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:48 PM ET
Size
7.1 KB
Accession
0001209191-23-001008
Insider Transaction Report
Form 4
Khan Samina
SVP, Chief Medical Officer
Transactions
- Award
Class A common stock
2023-01-03+11,756→ 46,905 total - Award
Employee Stock Option (right-to-buy)
2023-01-03+47,738→ 47,738 totalExercise: $36.71Exp: 2033-01-03→ Class A common stock (47,738 underlying)
Footnotes (2)
- [F1]The shares represent Restricted Stock Units, which vest 1/16th of each grant on March 6, May 15, August 15, and November 15 of each year, subject to continued service through each vesting date.
- [F2]The options vest 1/16th of each grant on March 6, May 15, August 15, and November 15 of each year, subject to continued service through each vesting date.
Documents
Issuer
REATA PHARMACEUTICALS INC
CIK 0001358762
Entity typeother
Related Parties
1- filerCIK 0001903865
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:48 PM ET
- Size
- 7.1 KB